会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • THERAPEUTIC COMPOSITION CONTAINING ENDOTHELIN AS AN ACTIVE COMPONENT
    • 含有内皮素作为活性成分的治疗组合物
    • WO2012138043A2
    • 2012-10-11
    • PCT/KR2011010320
    • 2011-12-29
    • SEOUL NAT UNIV HOSPITALLEE EUN JUKIM HYO SOO
    • LEE EUN JUKIM HYO SOO
    • A61K31/19A61P9/00A61P9/10
    • A61K38/2278
    • The present invention relates to a composition for preventing or treating ischemic disease comprising endothelin or a nucleotide sequence encoding endothelin as an active ingredient, and more particularly to a composition for preventing or treating ischemic heart disease, myocardial infarction, angina pectoris, lower limb artery ischemia, distal limb ischemia and ischemic cerebrovascular disease, wherein the composition is administered by intramuscular injection. According to the present invention, administering endothelin-1 by intramuscular injection may efficiently inhibit the progress of ischemia, fibrosis and tissue necrosis, and induce angiogenesis, such that it is promising for preventing or treating the ischemic disease.
    • 本发明涉及用于预防或治疗缺血性疾病的组合物,其包含内皮素或编码内皮素作为活性成分的核苷酸序列,更具体地涉及用于预防或治疗缺血性心脏病,心肌梗死,心绞痛,下肢动脉缺血的组合物 ,远端肢体缺血和缺血性脑血管疾病,其中所述组合物通过肌内注射施用。 根据本发明,通过肌内注射给予内皮素-1可有效抑制缺血,纤维化和组织坏死的进展,并诱导血管发生,从而有希望预防或治疗缺血性疾病。